Zia Ul Sabah is an expert in Biochemistry at King Khalid University (Saudi Arabia). Zia Ul Sabah has authored 24 publications, the most recent in 2025. SLR score: 55 (community average: 125). How the SLR is computed.

LeadR Profile

Zia Ul Sabah King Khalid University Saudi Arabia
55 ScienceLeadR Reputation 55
Network Map

Biochemistry

Subspecialties: Pediatrics - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2022 - 2026

Source: PubMed

King Khalid University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 24

Citations

Citations: 129 1st author: 5 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Low estimated glucose disposal rate predicts high residual syntax score in non-diabetic ST-elevation myocardial infarction patients.
PMID 41310853 — myocardial infarction, st elevation myocardial infarction
Diabetol Metab Syndr20250
The second survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and temporal changes in care (STARS-2 program).
PMID 40892777 — diabetes mellitus, registries, myocardial infarction, reperfusion
PLoS One20250
Association of Prognostic Nutritional Index with Post-Discharge Bleeding After Percutaneous Coronary Intervention in ACS Patients on DAPT.
PMID 40231032 — serum albumin, lymphocyte count, hemorrhage, serum, lymphocytes, percutaneous coronary intervention, cohort studies, acute coronary syndrome, blood platelets
Ther Clin Risk Manag20251
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions.
PMID 40141412 — insulin resistance, insulin, metabolic diseases, non-alcoholic fatty liver disease, dyslipidemias, inflammasomes, liver, signal transduction, therapeutics
Int J Mol Sci202512
Synergistic Effects of Diabetes and Smoking on Ticagrelor Antiplatelet Activity in ACS Patients Undergoing PCI
OpenAlex W4406113923 — diabetes mellitus, ticagrelor, smoking
Research Square (Research Square)20250

LeadR Networks

Main global connection map